DNMT3A and aortic stenosis: In conclusion, carrying a DNMT3A- and/or TET2-CHIP-driver mutation is an independent prognostic risk factor for increased long-term mortality in patients with severe aortic stenosis even after successful removal of the stenotic valve by TAVR.